CYDY OTC
CytoDyn Inc.
1W: -11.9%
1M: -4.3%
3M: -15.0%
YTD: -25.9%
1Y: -23.0%
3Y: +14.2%
5Y: -91.4%
$0.20
+0.00 (+0.50%)
Weekly Expected Move ±8.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+100.0% ▲
Gross Profit
-$17K
+5.6% ▲
Operating Income
-$22M
-292.6% ▼
Net Income
-$43M
-1240.2% ▼
EPS (Diluted)
$-0.03
-2005.6% ▼
EBITDA
-$22M
-352.9% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $266K | $0 | $0 | -$6M | $0 |
| YoY Growth | +0.0% | -100.0% | +0.0% | +0.0% | +100.0% |
| Cost of Revenue | $53K | $175K | $29K | $18K | $17K |
| Gross Profit | $213K | -$175K | -$29K | -$18K | -$17K |
| Gross Margin | 80.1% | — | — | 0.3% | — |
| R&D Expenses | $27M | $3M | $7M | $17M | $16M |
| SG&A Expenses | $44M | $17M | $11M | $7M | $7M |
| Operating Expenses | $72M | $40M | $18M | -$11M | $22M |
| Operating Income | -$145M | -$41M | -$18M | $11M | -$22M |
| Operating Margin | -54663.2% | — | — | -191.4% | — |
| Interest Expense | $52M | $25M | $9M | $5M | $3M |
| Income Before Tax | -$211M | -$80M | -$50M | $4M | -$43M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$211M | -$80M | -$50M | $4M | -$43M |
| Net Margin | -79255.6% | — | — | -63.3% | — |
| EPS (Diluted) | $-0.43 | $-0.10 | $-0.05 | $0.00 | $-0.03 |
| EBITDA | -$195M | -$40M | -$18M | $9M | -$22M |
| Shares Outstanding | 677M | 837M | 970M | 1.24B | 1.29B |